Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01841190
Verified March 2013 by José Raimundo Araujo de Azevedo, Hospital Sao Domingos. Recruitment status was: Recruiting
: April 26, 2013
Last Update Posted
: April 26, 2013
Hospital Sao Domingos
Information provided by (Responsible Party):
José Raimundo Araujo de Azevedo, Hospital Sao Domingos
The purpose of this study is to compare the tendency of plasma concentration and clearance of procalcitonin in the first 24 and 48 hours of management of patients with severe sepsis and septic shock with another marker of early prognosis represented by 48 hours delta sofa.
Condition or disease
Severe SepsisSeptic Shock
This is a cohort prospective observational study that will include adult patients admitted to a multidisciplinary ICU of a tertiary hospital.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Adult patients with severe sepsis and septic shock admitted to a multidisciplinary ICU